BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10233349)

  • 1. Ultraviolet-A1 phototherapy improves the status of the skin in cutaneous T-cell lymphoma.
    von Kobyletzki G; Dirschka T; Freitag M; Hoffman K; Altmeyer P
    Br J Dermatol; 1999 Apr; 140(4):768-9. PubMed ID: 10233349
    [No Abstract]   [Full Text] [Related]  

  • 2. Granulomatous slack skin responds to UVA1 phototherapy.
    Oberholzer PA; Cozzio A; Dummer R; French LE; Hofbauer GF
    Dermatology; 2009; 219(3):268-71. PubMed ID: 19546523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dermatologic phototherapy].
    Krutmann J
    Hautarzt; 1991 Jun; 42(6):407-14. PubMed ID: 1917466
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous type adult T-cell leukaemia/lymphoma successfully treated with narrowband ultraviolet B phototherapy.
    Kudo H; Fukushima S; Masuguchi S; Sakai K; Jinnin M; Ihn H
    Clin Exp Dermatol; 2012 Mar; 37(2):183-4. PubMed ID: 22082228
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma.
    Plettenberg H; Stege H; Megahed M; Ruzicka T; Hosokawa Y; Tsuji T; Morita A; Krutmann J
    J Am Acad Dermatol; 1999 Jul; 41(1):47-50. PubMed ID: 10411410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous gamma/delta T-cell lymphoma treated with retinoid and narrowband ultraviolet B.
    Nakashima H; Sugaya M; Minatani Y; Ohmatsu H; Asano N; Fujimoto M; Kikuchi K; Ihn H; Tamaki K
    Clin Exp Dermatol; 2009 Oct; 34(7):e345-6. PubMed ID: 19456763
    [No Abstract]   [Full Text] [Related]  

  • 7. An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report.
    Ibbotson SH; Bilsland D; Cox NH; Dawe RS; Diffey B; Edwards C; Farr PM; Ferguson J; Hart G; Hawk J; Lloyd J; Martin C; Moseley H; McKenna K; Rhodes LE; Taylor DK;
    Br J Dermatol; 2004 Aug; 151(2):283-97. PubMed ID: 15327535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel multimodality biologic response modifier therapy, including bexarotene and long-wave ultraviolet A for a patient with refractory stage IVa cutaneous T-cell lymphoma.
    Shapiro M; Rook AH; Lehrer MS; Junkins-Hopkins JM; French LE; Vittorio CC
    J Am Acad Dermatol; 2002 Dec; 47(6):956-61. PubMed ID: 12451388
    [No Abstract]   [Full Text] [Related]  

  • 9. Ultraviolet radiation for treatment of cutaneous T-cell lymphoma.
    Herrmann JJ; Roenigk HH; Hönigsmann H
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):1077-88. PubMed ID: 8522485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance Therapy for Cutaneous T-cell Lymphoma After Total Skin Electron Irradiation: Evidence for Improved Overall Survival With Ultraviolet Therapy.
    Kudelka MR; Switchenko JM; Lechowicz MJ; Esiashvili N; Flowers CR; Khan MK; Allen PB
    Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):757-767.e3. PubMed ID: 32703750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scabies associated with radiation therapy for cutaneous T-cell lymphoma.
    McGregor DH; Yang Q; Fan F; Talley RL; Topalovski M
    Ann Clin Lab Sci; 2001 Jan; 31(1):103-7. PubMed ID: 11314859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irradiation therapy: from UV light to electron beam.
    Panizzon RG
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():43-6. PubMed ID: 16412211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypopigmented macules in a young man. Hypopigmented mycoses fungoides.
    Ahmad Al Dhafiri S; Nast A; Jaser Al Shamary M
    J Dtsch Dermatol Ges; 2014 Mar; 12(3):272-4. PubMed ID: 24238331
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of syringotropic cutaneous T-cell lymphoma treated with local radiotherapy.
    Jacob R; Scala M; Fung MA
    J Am Acad Dermatol; 2009 Jan; 60(1):152-4. PubMed ID: 19103368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell primary cutaneous anaplastic large cell lymphoma mimicking appearance of large basal cell carcinoma.
    Lott DG; Akst LM; Greene D; Roberts JK
    Otolaryngol Head Neck Surg; 2006 Jul; 135(1):170-1. PubMed ID: 16815209
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of follicular cutaneous T-cell lymphoma without mucinosis with narrow-band UVB irradiation.
    Matsuoka Y; Yoneda K; Katsuura J; Moriue T; Nakai K; Sadahira C; Yokoi I; Nibu N; Demitsu T; Kubota Y
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1121-2. PubMed ID: 17714145
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary cutaneous aggressive epidermotropic CD8 positive cytotoxic T-cell lymphoma of the ear.
    Fika Z; Karkos PD; Badran K; Williams RE
    J Laryngol Otol; 2007 May; 121(5):503-5. PubMed ID: 17166330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous blastic natural killer cell lymphoma.
    Parlette EC; Elliott JZ; Hall FW; Graham BS
    J Am Acad Dermatol; 2005 Oct; 53(4):742-3. PubMed ID: 16198814
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of radiotherapy in a case of epidermotropic cutaneous lymphoma associated with granulomatous cutis laxa].
    Nouira R; Maalej M; Zili J; Denguezli M; Belajouza C; Jomaa B
    Bull Cancer Radiother; 1994; 81(2):147-50. PubMed ID: 7702895
    [No Abstract]   [Full Text] [Related]  

  • 20. Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.
    Funk A; Hensley F; Krempien R; Neuhof D; Van Kampen M; Treiber M; Roeder F; Timke C; Herfarth K; Helmbold P; Debus J; Bischof M
    Eur J Dermatol; 2008; 18(3):308-12. PubMed ID: 18474461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.